1. Home
  2. CCCT vs DTIL Comparison

CCCT vs DTIL Comparison

Compare CCCT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCCT

Columbus Circle Capital Corp III Class A Ordinary Shares

N/A

Current Price

$9.85

Market Cap

308.6M

Sector

N/A

ML Signal

N/A

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$7.35

Market Cap

362.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCCT
DTIL
Founded
2025
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.6M
362.6M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
CCCT
DTIL
Price
$9.85
$7.35
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $29.40
AVG Volume (30 Days)
27.3K
★ 402.8K
Earning Date
N/A
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.80
$3.53
52 Week High
$10.05
$11.29

Technical Indicators

Market Signals
Indicator
CCCT
DTIL
Relative Strength Index (RSI) 55.97 48.99
Support Level $9.80 $6.12
Resistance Level $9.88 $7.80
Average True Range (ATR) 0.00 0.93
MACD -0.00 -0.22
Stochastic Oscillator 40.00 17.63

Price Performance

Historical Comparison
CCCT
DTIL

About CCCT Columbus Circle Capital Corp III Class A Ordinary Shares

Columbus Circle Capital Corp III is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: